I do wonder why JnJ didn’t parter to distribute the product if they had first dibs? Maybe they think it will cut into their surgical portfolio?
Ann: Successful OrthoATI clinical trial, page-2
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $79.54M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 37.5¢ | $16.63K | 43.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 24480 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.17pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
38.0¢ |
Change
0.010 ( 1.33 %) |
||||
| Open | High | Low | Volume | ||
| 38.0¢ | 38.0¢ | 37.0¢ | 7580 | ||
| Last updated 15.46pm 24/05/2024 ? | |||||
| OCC (ASX) Chart |